2023 Stem Cells and Cancer Gordon Research Conference and Seminar

2023年干细胞与癌症戈登研究会议暨研讨会

• 批准号: 10683590
• 负责人: Kathrin Plath
• 金额: $ 0.7万
• 依托单位: GORDON RESEARCH CONFERENCES
• 依托单位国家: 美国
• 财政年份: 2023
• 资助国家: 美国
• 起止时间: 2023-03-06 至 2024-02-29
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10683590
• 关键词: Academia; Address; Advanced Development; Area; Automobile Driving; Basic Science; COVID-19 pandemic; Cancer Biology; Cancer Detection; Cellular biology; Collaborations; Communities; Country; Data; Development; Developmental Biology; Disease; Environment; Experimental Models; Feedback; Female; Fertilization; Future; Goals; Growth; Homeostasis; Industry; Italy; Knowledge; Learning; Malignant Neoplasms; Mentors; Mentorship; Metabolic; Metabolism; Methods; Michigan; Minority Groups; Molecular; Molecular Analysis; Neoplasm Metastasis; Organogenesis; Patient Care; Principal Investigator; Productivity; Regenerative Medicine; Request for Proposals; Research; Research Personnel; Role; Science; Scientist; Structure; Technology; Therapeutic; Tissues; Tumor Promotion; Underrepresented Minority; United States National Institutes of Health; Work; cancer cell; cancer initiation; cancer stem cell; cancer therapy; career; catalyst; cell behavior; cell growth; doctoral student; epigenomics; improved; in vivo; interest; meetings; member; neoplastic cell; novel; organ repair; patient prognosis; peer; peer networks; programs; repaired; stem cell aging; stem cell biology; stem cell fate; stem cells; symposium; synergism; tissue regeneration; training opportunity; tumor; tumor eradication; tumor growth; tumor heterogeneity; tumor initiation; tumor progression; tumorigenesis

PROJECT SUMMARY This proposal requests partial support for the eighth Gordon Research Conference on Stem Cells and Cancer, which will take place on May 14-19, 2023 in Lucca (Italy). The goal of this conference is to provide a forum for presentation, discussion and interaction among a diverse, interdisciplinary group of researchers with interests in stem cell biology, development, and cancer. In particular, we wish to highlight how principles taken from development can be used to better understand tumor initiation and metastasis. The meeting is chaired by Dr. Cedric Blanpain (Université Libre de Bruxelles), with Drs. Leanne Jones (UCSF) and Kathrin Plath (UCLA) serving as vice chairs. The planned agenda includes presentations from key leaders in the fields of cancer biology, stem cell biology and regenerative medicine, and thus will attract a highly interdisciplinary group of researchers who do not frequently interact at meetings. This meeting will, therefore, act as a catalyst for new collaborations and cross-fertilization of ideas, which is, of course, a long-term goal of the Gordon Research Conferences. The outstanding scientific program for the meeting highlights the diversity of contributors to this research area (48% of invited speakers are female and/or members of under-represented minority groups) and explores cutting-edge topics of particular interest to the National Institutes of Health (NIH), including but not limited to: developmental mechanisms known to regulate stem cell fate decisions and tissue homeostasis that are usurped for tumor formation, the role of metabolism in regulating stem cells, tissue homeostasis and tumor growth, and emerging therapies to promote tumor cell clearance, eradicate tumor-propagating stem cells and enhance organ repair. Additional speakers will be chosen from the submitted abstracts, with particular consideration given to those investigators from backgrounds traditionally underrepresented in the sciences. The 2023 Gordon Research Conference on Stem Cells and Cancer will also include a Gordon Research Seminar (GRS), a 2-day “pre-meeting” of early career scientists in a highly stimulating and inclusive environment that promotes the open exchange of information and establishment and growth of peer networks. The GRS will be held from May 12-13, 2023 at the same venue in Lucca, and is chaired by Dr. Tugba Topal (Univ. of Michigan) and supported by an organizing committee of three doctoral students: Clara Cano (UCLA), Andrea Pérez González (Université Libre de Bruxelles), and Nicholas Jackson (UCSF). The GRS provides additional opportunities for junior trainees to present their work and receive crucial feedback and mentorship both from their peers and from more established investigators, making this meeting a particularly valuable training opportunity for junior investigators. The specific set of integrated and complementary research topics that will be addressed in the 2023 Stem Cells and Cancer GRS/GRC is distinct from other conferences, and the unique structure of the GRS and GRC provides for productive interactions among scientists and trainees at different career stages in industry and academia who are addressing fundamental questions in the area using different experimental approaches.

项目概要 该提案请求对第八届戈登干细胞研究会议提供部分支持 Cancer，将于 2023 年 5 月 14 日至 19 日在卢卡（意大利）举行 本次会议的目标是提供一个 多元化、跨学科的研究人员群体之间进行展示、讨论和互动的论坛 我们特别希望强调的是对干细胞生物学、发育和癌症的兴趣。 从发育可以用来更好地了解肿瘤的发生和转移。 Cedric Blanpain 博士（布鲁塞尔自由大学）与 Leanne Jones 博士（加州大学旧金山分校）和 Kathrin Plath 博士（加州大学洛杉矶分校） 计划的议程包括癌症领域主要领导人的演讲。 生物学、干细胞生物学和再生医学，因此将吸引高度跨学科的团队 因此，不经常在会议上互动的研究人员将成为新会议的催化剂。 合作和思想的交叉融合，这当然是戈登研究的长期目标 会议的出色科学计划凸显了贡献者的多样性。 研究领域（48％的受邀演讲者是女性和/或代表性不足的少数群体成员）和 探讨美国国立卫生研究院 (NIH) 特别感兴趣的前沿主题，包括但不包括 仅限于：已知调节干细胞命运决定和组织稳态的发育机制 被篡夺用于肿瘤形成、代谢在调节干细胞、组织稳态和肿瘤中的作用 生长，以及促进肿瘤细胞清除、根除肿瘤增殖干细胞和的新兴疗法 将从提交的摘要中选择其他演讲者，特别是。 考虑到那些传统上在科学领域代表性不足的背景的研究人员。 2023 年戈登干细胞和癌症研究会议还将包括戈登研究研讨会 (GRS)，这是在一个高度刺激和包容的环境中为早期职业科学家举办的为期 2 天的“预会”， GRS 将促进信息的公开交流以及同行网络的建立和发展。 会议于 2023 年 5 月 12 日至 13 日在卢卡同一地点举行，由 Tugba Topal 博士（密歇根大学）主持 并得到了由三名博士生组成的组委会的支持：Clara Cano（加州大学洛杉矶分校）、Andrea Pérez González（布鲁塞尔自由大学）和 Nicholas Jackson（加州大学旧金山分校）提供了额外的信息。 为初级学员提供展示其工作并获得重要反馈和指导的机会 他们的同行和更成熟的研究人员，使这次会议成为一次特别有价值的培训 初级研究者的机会。 2023 年干细胞和癌症 GRS/GRC 会议的主题与其他会议不同，其独特的 GRS 和 GRC 的结构为不同领域的科学家和学员之间提供了富有成效的互动 工业界和学术界的职业阶段，他们使用不同的方法解决该领域的基本问题 实验方法。